HOXA9 forms a repressive complex with nuclear matrix–associated protein SAFB to maintain acute myeloid leukemia
Open Access
- 6 April 2023
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 141 (14) , 1737-1754
Abstract
HOXA9 is commonly upregulated in acute myeloid leukemia (AML), in which it confers a poor prognosis. Characterizing the protein interactome of endogenous HOXA9 in human AML, we identified a chromatin complex of HOXA9 with the nuclear matrix attachment protein SAFB. SAFB perturbation phenocopied HOXA9 knockout to decrease AML proliferation, increase differentiation and apoptosis in vitro, and prolong survival in vivo. Integrated genomic, transcriptomic, and proteomic analyses further demonstrated that the HOXA9-SAFB (H9SB)–chromatin complex associates with nucleosome remodeling and histone deacetylase (NuRD) and HP1γ to repress the expression of factors associated with differentiation and apoptosis, including NOTCH1, CEBPδ, S100A8, and CDKN1A. Chemical or genetic perturbation of NuRD and HP1γ–associated catalytic activity also triggered differentiation, apoptosis, and the induction of these tumor-suppressive genes. Importantly, this mechanism is operative in other HOXA9-dependent AML genotypes. This mechanistic insight demonstrates the active HOXA9-dependent differentiation block as a potent mechanism of disease maintenance in AML that may be amenable to therapeutic intervention by targeting the H9SB interface and/or NuRD and HP1γ activity.Keywords
This publication has 54 references indexed in Scilit:
- Notch pathway activation targets AML-initiating cell homeostasis and differentiationJournal of Experimental Medicine, 2013
- Improved Therapeutic Effect against Leukemia by a Combination of the Histone Methyltransferase Inhibitor Chaetocin and the Histone Deacetylase Inhibitor Trichostatin AJournal of Korean Medical Science, 2013
- Identification and characterization of Hoxa9 binding sites in hematopoietic cellsBlood, 2012
- Anti-leukemia activity of chaetocin via death receptor-dependent apoptosis and dual modulation of the histone methyl-transferase SUV39H1Leukemia, 2011
- Functional Crosstalk between Bmi1 and MLL/Hoxa9 Axis in Establishment of Normal Hematopoietic and Leukemic Stem CellsCell Stem Cell, 2011
- HOXA9 is required for survival in human MLL-rearranged acute leukemiasBlood, 2009
- HOX expression patterns identify a common signature for favorable AMLLeukemia, 2008
- A distal single nucleotide polymorphism alters long-range regulation of the PU.1 gene in acute myeloid leukemiaJournal of Clinical Investigation, 2007
- Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1bThe EMBO Journal, 1998
- Novel nuclear matrix protein HET binds to and influences activity of the HSP27 promoter in human breast cancer cellsJournal of Cellular Biochemistry, 1997